title: Defining the Safety of Anacetrapib, a CETP Inhibitor, in Patients at High Risk for Coronary Heart Disease: the DEFINE study.
authors.affiliation: Division of Preventive Medicine, Department of Medicine, and the UAB Diabetes Research and Training Center, University of Alabama at Birmingham, Medical Towers 734, 1717 11th Avenue South Birmingham, AL 35205, USA. clewis@dopm.uab.edu.
authors.forename: Cora E
authors.initials: CE
authors.lastname: Lewis
references.citation: Circulation. 2004 Jul 13;110(2):227-39
references.pmid: 15249516
references.citation: Cardiovasc Ther. 2011 Oct;29(5):327-39
references.pmid: 20406242
references.citation: N Engl J Med. 2007 Nov 22;357(21):2109-22
references.pmid: 17984165
references.citation: Am Heart J. 2009 Oct;158(4):513-519.e3
references.pmid: 19781408
references.citation: JAMA. 2008 Jun 18;299(23):2777-88
references.pmid: 18560005
references.citation: Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1430-8
references.pmid: 20448206
references.citation: Am Heart J. 2009 Feb;157(2):352-360.e2
references.pmid: 19185645